Evidence map›Paper›PMID 29764860›Full record

ArticleDiabetes2018

Membrane-Initiated Estrogen Receptor Signaling Mediates Metabolic Homeostasis via Central Activation of Protein Phosphatase 2A.

Kazutaka Ueda, Eiki Takimoto, Qing Lu, Pangyen Liu, Nobuaki Fukuma, Yusuke Adachi, Ryo Suzuki, Shengpu Chou, Wendy Baur, Mark J Aronovitz and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Pediatric reports · 2024
    Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Quantum-based modeling implies that bidentate ArgFrontiers in cell and developmental biology · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Kazutaka UedaMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA.ORCID 0000-0002-0509-1840
Eiki TakimotoDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Qing LuMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA.
Pangyen LiuDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Nobuaki FukumaDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Yusuke AdachiDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Ryo SuzukiDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Shengpu ChouDepartment of Diabetes and Metabolic Diseases, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
Wendy BaurMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA.
Mark J AronovitzMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA.
Andrew S GreenbergObesity and Metabolism Laboratory, U.S. Department of Agriculture Human Nutrition Research Center on Aging at Tufts University, Boston, MA.ORCID 0000-0001-5062-387X
Issei KomuroDepartment of Cardiovascular Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan komuro-tky@umin.ac.jp richard.karas@gmail.com.
Richard H KarasMolecular Cardiology Research Institute, Tufts Medical Center, Boston, MA komuro-tky@umin.ac.jp richard.karas@gmail.com.ORCID 0000-0001-7799-091X
The University of Tokyo · JPTufts Medical Center · USTufts University · US

Funding

Transgenic CoreP30DK046200 · NIDDK · TUFTS MEDICAL CENTER · PI CORKEY, BARBARA E. · 1992 to 2021
$25.0M
VASCULAR ESTROGEN RECEPTOR SIGNALING PATHWAYSR01HL061298 · NHLBI · TUFTS MEDICAL CENTER · PI KARAS, RICHARD H · 1999 to 2012
$4.4M
NHLBI NIH HHS R01 HL061298NIDDK NIH HHS P30 DK046200
6 · The paper itself

Abstract

Women gain weight and their diabetes risk increases as they transition through menopause; these changes can be partly reversed by hormone therapy. However, the underlying molecular mechanisms mediating these effects are unknown. A novel knock-in mouse line with the selective blockade of the membrane-initiated estrogen receptor (ER) pathway was used, and we found that the lack of this pathway precipitated excessive weight gain and glucose intolerance independent of food intake and that this was accompanied by impaired adaptive thermogenesis and reduced physical activity. Notably, the central activation of protein phosphatase (PP) 2A improved metabolic disorders induced by the lack of membrane-initiated ER signaling. Furthermore, the antiobesity effect of estrogen replacement in a murine menopause model was abolished by central PP2A inactivation. These findings define a critical role for membrane-initiated ER signaling in metabolic homeostasis via the central action of PP2A.

Indexed as

Estrogen Replacement TherapyMenopause3T3-L1 CellsAdipocytesAdiposityAmino Acid SubstitutionAnimalsCells, CulturedDiet, High-FatEnzyme ActivationEstradiolEstrogen Receptor alphaFemaleGene Knock-In TechniquesGlucose IntoleranceInsulin ResistanceEstradiolEstrogen Receptor alphaProtein Phosphatase 2

Identifiers

PMID29764860
PMCPMC6054435
OpenAlexW2803267200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.